Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, Wuhan University, 430072, Wuhan, P. R. China.
Angew Chem Int Ed Engl. 2020 Apr 6;59(15):5965-5971. doi: 10.1002/anie.201911712. Epub 2020 Feb 21.
DNAzymes have been recognized as promising transducing agents for visualizing endogenous biomarkers, but their inefficient intracellular delivery and limited amplification capacity (including insufficient cofactor supply) preclude their extensive biological application. Herein, an autocatalytic DNAzyme (ACD) biocircuit is constructed for amplified microRNA imaging in vivo based on a hybridization chain reaction (HCR) and DNAzyme biocatalysis, sustained by a honeycomb MnO nanosponge (hMNS). The hMNS not only delivers DNA probes, but also supplies Mn as a DNAzyme cofactor and magnetic resonance imaging (MRI) agent. Through the subsequent cross-activation of HCR and DNAzyme amplicons, the ACD amplifies the limited signal resulting from miRNA recognition. The hMNS/ACD system was used to image microRNA in vivo, thus demonstrating its great promise in cancer diagnosis.
DNA 酶已被认为是可视化内源性生物标志物的有前途的转导剂,但它们的细胞内传递效率低和扩增能力有限(包括辅助因子供应不足)限制了它们的广泛生物学应用。在此,基于杂交链式反应 (HCR) 和 DNA 酶生物催化作用,构建了一个自催化 DNA 酶 (ACD) 生物电路,用于基于蜂窝状 MnO 纳米海绵 (hMNS) 的体内放大 miRNA 成像。hMNS 不仅传递 DNA 探针,还提供 Mn 作为 DNA 酶辅助因子和磁共振成像 (MRI) 造影剂。通过 HCR 和 DNA 酶扩增子的后续交叉激活,ACD 放大了 miRNA 识别产生的有限信号。hMNS/ACD 系统用于体内成像 microRNA,从而证明其在癌症诊断中有很大的应用前景。